TCR2 Therapeutics Inc (NASDAQ:TCRR)
| 1.49 Delayed Data As of 3:59pm ET |  0.00 / 0.00%Today’s Change | 0.82 Today|||52-Week Range 3.88 | +49.18% Year-to-Date |
Largest transactions by value over
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Menzel Garry E President & Chief Executive Officer |  Sale | 12/06/2022 | 14,886 | $1.35 | $20.1K | +13.21% |
Menzel Garry E President & Chief Executive Officer | Sale | 12/02/2022 | 8,408 | $1.39 | $11.7K | +6.38% |
Menzel Garry E President & Chief Executive Officer | Sale | 12/05/2022 | 8,530 | $1.37 | $11.7K | +9.49% |
Menzel Garry E President & Chief Executive Officer | Sale | 12/12/2022 | 10,613 | $1.10 | $11.7K | +35.14% |
Menzel Garry E President & Chief Executive Officer | Sale | 12/09/2022 | 10,325 | $1.13 | $11.7K | +31.58% |
Menzel Garry E President & Chief Executive Officer | Sale | 12/07/2022 | 9,111 | $1.28 | $11.7K | +18.11% |
Menzel Garry E President & Chief Executive Officer | Sale | 12/13/2022 | 11,000 | $1.06 | $11.7K | +50.00% |
Menzel Garry E President & Chief Executive Officer | Sale | 12/08/2022 | 9,314 | $1.25 | $11.6K | +27.12% |
Quintas Cardama Alfonso Chief Medical Officer | Sale | 12/08/2022 | 4,014 | $1.26 | $5.1K | +27.12% |
Quintas Cardama Alfonso Chief Medical Officer | Sale | 12/02/2022 | 3,636 | $1.39 | $5.1K | +6.38% |
Page of 5